losartan has been researched along with Mucocutaneous Lymph Node Syndrome in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Mucocutaneous Lymph Node Syndrome: An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Besides its antihypertensive effects, losartan can modulate inflammation in cardiovascular disease." | 7.85 | Losartan attenuates the coronary perivasculitis through its local and systemic anti-inflammatory properties in a murine model of Kawasaki disease. ( Aiba, Y; Hayashi, K; Kato, M; Koga, Y; Matsuda, S; Mochizuki, H; Nakamura, H; Niimura, F; Sekine, K; Suganuma, E; Takahashi, O; Ukawa, T, 2017) |
| " Besides its antihypertensive effects, losartan can modulate inflammation in cardiovascular disease." | 3.85 | Losartan attenuates the coronary perivasculitis through its local and systemic anti-inflammatory properties in a murine model of Kawasaki disease. ( Aiba, Y; Hayashi, K; Kato, M; Koga, Y; Matsuda, S; Mochizuki, H; Nakamura, H; Niimura, F; Sekine, K; Suganuma, E; Takahashi, O; Ukawa, T, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suganuma, E | 1 |
| Niimura, F | 1 |
| Matsuda, S | 1 |
| Ukawa, T | 1 |
| Nakamura, H | 1 |
| Sekine, K | 1 |
| Kato, M | 1 |
| Aiba, Y | 1 |
| Koga, Y | 1 |
| Hayashi, K | 1 |
| Takahashi, O | 1 |
| Mochizuki, H | 1 |
1 other study available for losartan and Mucocutaneous Lymph Node Syndrome
| Article | Year |
|---|---|
Losartan attenuates the coronary perivasculitis through its local and systemic anti-inflammatory properties in a murine model of Kawasaki disease.
Topics: Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Cell Wall; Chemokine CCL2; Disease Models | 2017 |